MC
ABBV icon

Maverick Capital’s AbbVie ABBV Stock Holding History

Maverick Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-6,073
Closed -$905K – 350
2023
Q3 		$905K Buy
+6,073
New +$892K 0.02% 130
2021
Q4 		– Sell
-11,681
Closed -$1.26M – 312
2021
Q3 		$1.26M Sell
11,681
-2,598
-18% -$297K 0.01% 244
2021
Q2 		$1.61M Buy
+14,279
New +$1.61M 0.02% 193
2021
Q1 		– Sell
-6,210
Closed -$665K – 690
2020
Q4 		$665K Buy
6,210
+4,188
+207% +$402K 0.01% 309
2020
Q3 		$177K Buy
+2,022
New +$190K ﹤0.01% 500
2017
Q3 		– Sell
-57,400
Closed -$4.16M – 178
2017
Q2 		$4.16M Buy
57,400
+13,000
+29% +$874K 0.05% 42
2017
Q1 		$2.89M Sell
44,400
-6,520
-13% -$410K 0.04% 53
2016
Q4 		$3.19M Buy
50,920
+1,320
+3% +$80.6K 0.04% 64
2016
Q3 		$3.13M Sell
49,600
-940
-2% -$60.9K 0.04% 66
2016
Q2 		$3.13M Buy
50,540
+7,370
+17% +$449K 0.04% 51
2016
Q1 		$2.47M Buy
+43,170
New +$2.41M 0.04% 48
2015
Q3 		– Sell
-3,950
Closed -$265K – 117
2015
Q2 		$265K Sell
3,950
-370
-9% -$24.2K ﹤0.01% 85
2015
Q1 		$253K Buy
+4,320
New +$261K ﹤0.01% 100
2014
Q4 		– Sell
-4,723,578
Closed -$273M – 46
2014
Q3 		$273M Buy
4,723,578
+1,488,445
+46% +$82.6M 3.99% 8
2014
Q2 		$183M Buy
+3,235,133
New +$170M 2.62% 16

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Maverick Capital's ABBV Position: Q4 2023 in Review

Maverick Capital sold out of AbbVie (ABBV) in Q4 2023, closing a stake of 6,073 shares — an estimated $905K sold.

Maverick Capital first reported a position in ABBV in Q2 2014 and held it in 15 quarters. The position peaked at $273M in Q3 2014. 3,327 funds tracked by Wall St. Rank hold ABBV as of Q4 2023.

  • Maverick Capital reported no remaining AbbVie position as of Q4 2023 after selling out during the quarter.
  • Maverick Capital sold 6,073 AbbVie shares in Q4 2023, an estimated $905K.
  • Maverick Capital first reported a position in AbbVie in Q2 2014 and held it in 15 quarters.
  • Maverick Capital's AbbVie position peaked at $273M in Q3 2014.
  • 3,327 funds tracked by Wall St. Rank held AbbVie as of Q4 2023.

Based on Maverick Capital's 13F filing for Q4 2023, filed 14 Feb 2024.